• Info
  • Significant Ownership

Significant Ownership of Growth Equity Opportunities 18 VGE, LLC

Signature - Title
/s/ Zachary Bambach - Zachary Bambach as attorney-in-fact for Anthony A. Florence Jr., Managing Partner and Co-Chief Executive Officer
Location
Timonium, MD
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Growth Equity Opportunities 18 VGE, LLC.

Notify me when Growth Equity Opportunities 18 VGE, LLC files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Growth Equity Opportunities 18 VGE, LLC

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
XFOR X4 Pharmaceuticals, Inc. Common Stock, par value $0.001 per share 6.2% $17,496,802 +$9,734,867 5,057,610 +125% Growth Equity Opportunities 18 VGE, LLC 27 Oct 2025
CELC Celcuity Inc. Common Stock, $0.001 par value per share 4.9% $238,224,023 -$65,143,750 2,285,561 -21% Growth Equity Opportunities 18 VGE, LLC 05 Mar 2026
GOSS Gossamer Bio, Inc. Common Stock, $0.0001 par value per share 1.7% $10,366,092 4,065,134 Growth Equity Opportunities 18 VGE, LLC 23 Feb 2026

Schedules 13D/G Reported by Growth Equity Opportunities 18 VGE, LLC:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.